Does diagnostic testing always decrease antibiotics prescriptions?, Springer. Read here.
The Opportunity of Point-of-Care Diagnostics in General Practice: Modelling the Effects on Antimicrobial Resistance, Springer. Read here.
Point of care testing, antibiotic prescribing and prescribing confidence for respiratory tract infections in primary care: Prospective audit in 18 European countries, BJGP Open. Read here
Health‑Economic Analyses of Diagnostics: Guidance on Design and Reporting, Pharmaco Economics. Read here
Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model, Health Economics Review. Read here
Primary care for patients with respiratory tract infection before and early on in the COVID-19 pandemic: an observational study in 16 European countries, British Medical Journal. Read here
Economic Analyses of Respiratory Tract Infection Diagnostics: A Systematic Review, Springer Nature. Read here
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis, Clinical Microbiology and Infection. Read here
Multi-Criteria Decision Analysis to prioritise hospital admission of patients affected by COVID-19 in settings with hospital-bed shortage, ScienceDirect. Read here
Overview of AMR-related resources and services, public report. Read here
Deliverable 5.4: Recommendations for innovative fit for purpose pricing and funding models for CA-ARTI diagnostics. Read here
VALUE-Dx Task 3.4 Modelling report. Read here
HTA, Reimbursement and Pricing of Diagnostic Tests for CA-ARTI – An international overview of policies (Task 5.5). Read here
Interoperable Networks for AMR Laboratory Data – An overarching review of Task 3.4 and federated networking. Read here
OHDSI-OMOP – A proposed standard for AMR data Modelling: Readiness and Recommendations (Task 3.4). Read here
POC 1 Infrastructure documentation (Task 3.4). Read here)